These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4269397)

  • 41. Lipoprotein (a): purification and kinetic analysis.
    Edelberg JM; Lee YJ; Young TN; Pizzo SV
    Methods Enzymol; 1993; 223():272-88. PubMed ID: 8271958
    [No Abstract]   [Full Text] [Related]  

  • 42. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit.
    Voss R; Matthias FR; Borkowski G; Reitz D
    Br J Haematol; 1990 May; 75(1):99-105. PubMed ID: 1695855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Additional potentials of a method of standard fibrin plates].
    Kovalenko AN
    Lab Delo; 1980; (10):615-8. PubMed ID: 6158612
    [No Abstract]   [Full Text] [Related]  

  • 44. [Non-enzymatic fibrinolysis in patients with hypertensive disease].
    Panchenko VM; Ol'khin VA; Kudriashov BA; Liapina LA
    Kardiologiia; 1973 Aug; 13(8):83-8. PubMed ID: 4272779
    [No Abstract]   [Full Text] [Related]  

  • 45. [Plasminogen activation and regulation of fibrinolysis].
    Madoiwa S
    Nihon Rinsho; 2014 Jul; 72(7):1218-23. PubMed ID: 25163311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelium and fibrinolysis.
    Todd AS
    Bibl Anat; 1973; 12():98-105. PubMed ID: 4275208
    [No Abstract]   [Full Text] [Related]  

  • 47. Resting levels of blood fibrinolysis in hyperlipoproteinemia.
    Brakman P; Astrup T; Levy RI; Fredrickson DS
    J Appl Physiol; 1974 Apr; 36(4):430-3. PubMed ID: 4274385
    [No Abstract]   [Full Text] [Related]  

  • 48. Fibrinolytic activity in hepatic cirrhosis.
    Blatný J; Seidlová V; Pelikán V; Fischerová E
    Digestion; 1972; 6(3):165-72. PubMed ID: 4269338
    [No Abstract]   [Full Text] [Related]  

  • 49. The preparation and evaluation of a standardized fibrin plate for the assessment of fibrinolytic activity.
    Bishop R; Ekert H; Gilchrist G; Shanbrom E; Fekete L
    Thromb Diath Haemorrh; 1970 May; 23(2):202-10. PubMed ID: 4246603
    [No Abstract]   [Full Text] [Related]  

  • 50. Theoretical and practical (clinical) considerations concerning proteolytic enzymes and their inhibitors with particular reference to changes in the plasminogen-plasmin system observed during assisted circulation in man.
    Gans H; Subramanian V; John S; Castaneda AR; Lillehei CW
    Ann N Y Acad Sci; 1968 Jun; 146(2):721-36. PubMed ID: 4239441
    [No Abstract]   [Full Text] [Related]  

  • 51. The reliability of plasminogen estimation by activation potential. On the heterogeneity of plasminogen in human plasma.
    Wolf P
    Bibl Anat; 1973; 12():286-91. PubMed ID: 4275206
    [No Abstract]   [Full Text] [Related]  

  • 52. [Nonenzymatic fibrinolysis in patients with ischemic heart disease].
    Panchenko VM; Liapina LA
    Kardiologiia; 1974 Nov; 14(11):14-8. PubMed ID: 4279308
    [No Abstract]   [Full Text] [Related]  

  • 53. The fibrinolytic system of plasma after electroshock.
    Hilden M; Lauritsen O
    Scand J Clin Lab Invest; 1971 Dec; 28(4):435-7. PubMed ID: 4258036
    [No Abstract]   [Full Text] [Related]  

  • 54. [Assay of fibrinolytic factors with plasminogen-free bovine fibrin-agar-plate and its clinical application. I. Some properties of plate and features for estimation of fibrinolytic factors (author's transl)].
    Abe T; Kazama M; Satoh A; Suzuki J; Yamamoto S
    Rinsho Ketsueki; 1975 Oct; 16(10):946-52. PubMed ID: 128644
    [No Abstract]   [Full Text] [Related]  

  • 55. Fibrinolytic activity of human veins.
    Pandolfi M; Nilsson IM; Robertson B; Isacson S
    Lancet; 1967 Jul; 2(7507):127-8. PubMed ID: 4165641
    [No Abstract]   [Full Text] [Related]  

  • 56. Antiplasmins.
    Norman PS
    Fed Proc; 1966; 25(1):63-7. PubMed ID: 4143744
    [No Abstract]   [Full Text] [Related]  

  • 57. [Correlation between fibrinolysis and the indexes of blood coagulation and of hepatic damage in chronic liver disease and liver cirrhosis].
    Craveri A; Cerrini R; Repaci G; Saracino F
    G Clin Med; 1968 Dec; 49(12):1326-53. PubMed ID: 4242987
    [No Abstract]   [Full Text] [Related]  

  • 58. [Thromboembolic complications, the coagulation and fibrinolytic blood system in heart defects with pronounced circulatory insufficiency].
    Gritsiuk AI
    Kardiologiia; 1969 Sep; 9(9):21-8. PubMed ID: 4244024
    [No Abstract]   [Full Text] [Related]  

  • 59. The use of N-ethyl-urethan in plasma plasminogen assay.
    Jacobsen CD
    Scand J Clin Lab Invest; 1968; 21(2):182-6. PubMed ID: 4236695
    [No Abstract]   [Full Text] [Related]  

  • 60. Fibrin plate method with reagents purified by affinity chromatography and its use for determination of fibrinolytic and other proteolytic activity in saliva, bile and plasma.
    Norén I; Ramström G; Wallén P
    Haemostasis; 1975; 4(2):110-24. PubMed ID: 1332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.